ANTIGEN DETERMINANT PEPTIDES AND A PROCESS FOR THE PREPARATION THEREOF
Antigen determinant peptides of the general formula I H - Val - X - Y (I) in which X represents an octapeptidic to undecapeptidic sequence of a defined structure Tyr-Tyr-Arg-Asp-Ser-Arg-Asn-Pro-Leu, Phe-Ile-His-Asn-Phe-Lys-Arg-Lys-Gly, Val-Pro-Arg-Arg-Lys-Ala-Lys-Ile, Leu-His-Thr-Gly-Glu-Arg-Asp-Trp...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Antigen determinant peptides of the general formula I
H - Val - X - Y (I)
in which X represents an octapeptidic to undecapeptidic sequence of a defined structure
Tyr-Tyr-Arg-Asp-Ser-Arg-Asn-Pro-Leu,
Phe-Ile-His-Asn-Phe-Lys-Arg-Lys-Gly,
Val-Pro-Arg-Arg-Lys-Ala-Lys-Ile,
Leu-His-Thr-Gly-Glu-Arg-Asp-Trp-His-Leu-Gly,
Ser-Gly-Lys-Ala-Arg-Gly-Trp-Phe
or Ser-Ile-Glu-Trp-Arg-Lys-Lys-Arg-Tyr-Ser
and Y stands for a hydroxyl or an amino group,
available by fragment synthesis or successive condensation of the respective amino acid residues (stepwise build-up) in solution or on a solid carrier, are expected to be of use as diagnostic agents for the so-called acquired immunodeficiency syndrome (AIDS), and also to have a potential as monodeterminant antibodies and safe synthetic vaccine agents combating the human T-cell lymphotropic type III virus (HTLV-III, HIV). |
---|